Speaker Profile
Ph.D., Chief Scientific Officer, Precede Biosciences
Biography
Dr. J. Carl Barrett is a renowned professional in the field of translational medicine and diagnostics with over 17 years of experience in drug development and technology advancement. In his previous role as the Vice President and Head of Oncology Translational Medicine at AstraZeneca Pharmaceuticals, he led a global team, spearheading biomarker strategy and translational sciences to support oncology drug development. Dr. Barrett's career also includes leadership positions at Novartis Institutes for BioMedical Research and the National Cancer Institute. He has made significant contributions to the field, with over 600 publications to his name and a reputation for mentoring future leaders in the pharmaceutical and biomedical sectors. Driven by a passion for lifelong learning and effective communication, he continues to shape the landscape of healthcare innovation.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Adrian Lee, UPMC
- PMWC Award Ceremony
Pioneer Honoree: Victor Velculescu, Johns Hopkins
Luminary Honoree: Nicola Aceto, ETH Zurich
- Keynote: Early Detection of Cancer using Cell-free DNA Fragmentomes
- Victor Velculescu, Johns Hopkins - Keynote: The Power of a Blood Sample: Predictive Diagnostics and Transforming Healthcare
- Matthew Rabinowitz, Natera - Improving Sensitivity of MRD and MCED - Tumor-agnostic vs. Tumor-informed ctDNA Approaches
Chair: Adrian Lee, University of Pittsburgh
- Marija Balic, UPMC
- Ola Carl Landgren, University of Miami
- Carl Barrett, Precede Biosciences
- Jonathan Beer, BMS
- Innovative Approaches in Liquid Biopsy
Chair: Victor Velculescu, Johns Hopkins
- Adam Widman, MSKCC
- Brian Hashemi, Novigenix
- Sequencing Accuracy in Early Detection and MRD (PANEL)
Chair: Alex Sockell, PacBio
- James Hadfield, AstraZeneca
- Keynote: Keynote: Circulating Tumor Cells
- Nicola Aceto, ETH Zurich - Circulating Tumor Cells: The New Frontier
Chair: Nicola Aceto, ETH Zurich
- Min Yu, University of Maryland School of Medicine
- Matteo Ligorio, UTSW - Precision Liquid Biopsies: Innovations Across the Cancer Continuum – From Early Detection to Long-Term Monitoring
Chair: Tom Beer, Exact Sciences
- Elizabeth (Betsy) O’Donnell, Dana Farber Cancer Institute
- Arnaud Papin, Merck
- PMWC Showcase
- Wendy Winckler, Droplet Biosciences - Multi-Cancer Early Detection: Innovations and Real-World Evidence (PANEL)
Chair: Peter Bach, Delfi Dx
- Joshua Cohen, Haystack
- Lauren Leiman, BLOODPAC
- Eric Klein, Grail Bio
- Tom Beer, Exact Sciences - PMWC Showcase
- Varsha Rao, Claret Bio - PMWC Award Ceremony and Keynote
Luminary Honoree: Matthew Rabinowitz, Natera
